Business · 09/09/2015Updated: 10/17/2026 · 1 min read
FDA Clears Way for Abbreviated New Drug Applications for GLUCAGON (Glucagon Hydrochloride) for Injection
Summary
The FDA has determined that GLUCAGON (glucagon hydrochloride) for injection, equivalent to 1 milligram base/vial and equivalent to 10 milligram base/vial, was not withdrawn from sale for reasons of safety or effectiveness, paving the way for the approval of abbreviated new drug applications for this medication.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →